Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)UnknownNCT03437603
What this trial is testing

Eltrombopag For Secondary Poor Graft Function Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Poor Graft Function
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Early research (Phase 1)UnknownNCT05576181
What this trial is testing

Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
Fundamenta Therapeutics, Ltd. 19
Large-scale testing (Phase 3)Not Yet RecruitingNCT05497401
What this trial is testing

A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS

Who this might be right for
ARDS
BonusBio Group Ltd 300
Testing effectiveness (Phase 2)Ended earlyNCT01602328
What this trial is testing

Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects

Who this might be right for
Acute Kidney Injury
AlloCure Inc. 156
Not applicableUnknownNCT02172365
What this trial is testing

Allogeneic SCT for CML, TKI Failure After TKI Failure

Who this might be right for
Chronic Myeloid Leukemia
University Health Network, Toronto 350
Not applicableNo Longer AvailableNCT01945619
What this trial is testing

Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)

Who this might be right for
EBV InfectionCMV InfectionAdenoviral Infection
Baylor College of Medicine
Testing effectiveness (Phase 2)Active Not RecruitingNCT00882895
What this trial is testing

Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Washington University School of Medicine 18
Testing effectiveness (Phase 2)Study completedNCT01590628
What this trial is testing

Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies

Who this might be right for
Sickle Cell Disease & Thalassemia
Gamida Cell ltd 16
Early research (Phase 1)Not Yet RecruitingNCT07617012
What this trial is testing

The Safety, Tolerability, and Efficacy of Dopaminergic Neural Progenitor Cells (XS411CN Cell Injection) for the Treatment of Multiple System Atrophy Parkinsonian Variant (MSA-P).

Who this might be right for
the Treatment of Multiple System Atrophy Parkinsonian Variant (MSA-P)
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. 3
Not applicableLooking for participantsNCT07013370
What this trial is testing

Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Immunoglobulin ProphylaxisCytomegalovirus InfectionsAllogeneic Hematopoietic Stem Cell Transplantation+1 more
Antonello Di Paolo, M.D., Ph.D. 150
Early research (Phase 1)Study completedNCT00705120
What this trial is testing

Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation

Who this might be right for
Osteogenesis Imperfecta
St. Jude Children's Research Hospital 9
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Testing effectiveness (Phase 2)UnknownNCT05413356
What this trial is testing

Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome

Who this might be right for
Bronchiolitis Obliterans SyndromeHematologic Malignancy
First Affiliated Hospital of Zhejiang University 50
Testing effectiveness (Phase 2)Study completedNCT03267186
What this trial is testing

Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Andrew Rezvani 8
Large-scale testing (Phase 3)Study completedNCT00421174
What this trial is testing

Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)

Who this might be right for
PneumoniaIdiopathic Pneumonia Syndrome
National Heart, Lung, and Blood Institute (NHLBI) 37
Testing effectiveness (Phase 2)WithdrawnNCT02167360
What this trial is testing

Study of Efficacy and Safety of CTL019 in Adult ALL Patients

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Ended earlyNCT01174082
What this trial is testing

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT02687646
What this trial is testing

Clinical Trial With MSC for Graft Versus Host Disease Treatment

Who this might be right for
Acute Graft Versus Host Disease
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 16
Next Page